U

UntilLabs

Advances reversible organ cryopreservation technology

Research Associate - Organ Perfusion

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeCalifornia, USAIn-person

About the Job

Requirements

  • You have an undergraduate degree in a STEM field, or significant STEM-related training
  • You have 2 years experience and an excellent record of success performing complex and demanding laboratory procedures, ideally with training in ex vivo organ perfusion and viability assessment.
  • You have demonstrated a passion for rapid problem solving and exploration of novel topics / protocols.
  • Desire to work in a laboratory setting.
  • You have experience or interest in physiology, with a creative approach to understanding and manipulating functions of organs.
  • You demonstrate agency, problem solving, passion for discovery, and a drive to push the boundaries of science through meaningful involvement in an ambitious project.

Responsibilities

  • Perform pig organ isolation and ex-vivo evaluation protocols, including perfusion and histology
  • Work within scientific team to evaluate health of organs following cryopreservation
  • Survey literature and conduct experimental tests to answer critical questions towards optimizing preservation protocol
  • Ensure accurate sample processing and on-time data reporting

About the Company

UntilLabs

Advances reversible organ cryopreservation technology

UntilLabs develops reversible cryopreservation technology to extend the viability of human organs for transplantation. The goal is to keep organs alive at cryogenic temperatures long enough to improve organ matching and reduce waste from time limits, potentially weeks or months of preserved time. The approach uses cooling to very low temperatures (below -130°C) with cryoprotectants to prevent ice damage, followed by advanced warming methods to revive the organs without harm. While cryopreservation has worked for cells and simple tissues, UntilLabs works on scaling this to whole organs, tackling challenges like ice formation and nutrient/waste management in large tissues. In the long term, the company envisions whole-body reversible cryopreservation as a bridge to future medical cures.

Company size
51-200
Company stage
Series A
Total funding
$58M
Headquarters
San Francisco, CA
Founded
2024

Recently Posted Jobs

Explore more opportunities at UntilLabs

See more jobs